More on BMRA
Data
Financials
Upcoming Events
News
Click line-items for a historical chart and %
| Net income (loss) | -55.42K |
| Depreciation and amortization | 52.98K |
| Change in provision for losses on accounts receivable | -192 |
| Inventory reserve | -9.97K |
| Increase in deferred rent liability | |
| Accounts receivable | 650 |
| Inventories | 22.61K |
| Prepaid expenses and other assets | -21.65K |
| Accounts payable and accrued expenses | -62.81K |
| Accrued compensation | 9.2K |
| Net cash provided by (used in) operating activities | -71.93K |
| Intangibles | 0 |
| Purchases of property and equipment | 0 |
| Net cash used in investing activities | 0 |
| Payment of equipment loan | |
| Net cash used in financing activities | 0 |
| Effect of exchange rate changes on cash | 26 |
| Net increase (decrease) in cash and cash equivalents | -71.91K |
| Cash and cash equivalents at beginning of period | |
| Cash and cash equivalents at end of period | |
| Cash paid during the quarter for Interest | 0 |
Entities mentioned with BMRA
- FDA | View Related Stories »
- Earnings | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- 13G | View Related Stories »
- S3 | View Related Stories »
- B. Riley | View Related Stories »
- Show More...
